NEXTHERA CAPITAL LP

13F Filings History

Latest 13F report
Q2 2019 - Aug 14, 2019
Value $
$120M
Signature - Title
Daniel Malek - Managing Member/CEO
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by NEXTHERA CAPITAL LP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. NEXTHERA CAPITAL LP reported 23 stock holdings with total value $120M as of Q2 2019. Top holdings included ICPT, INSM, BOLD, NBIX, and SRPT.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2019 23 $120M +$76.3M -$36.3M +$39.9M ICPT, INSM, BOLD, NBIX, SRPT 13F-HR 8/14/2019, 04:08 PM
Q1 2019 24 $82.4M +$23.7M -$140M -$116M BOLD, HRTX, INSM, IMMU, BHC 13F-HR 5/15/2019, 04:06 PM
Q4 2018 20 $152M +$72.8M -$256M -$183M NVS, HRTX, BOLD, IMMU, BHC 13F-HR 2/14/2019, 04:00 PM
Q3 2018 50 $371M +$136M -$174M -$38.2M EXEL, AGN, IMMU, MYL, DOVA 13F-HR 11/14/2018, 04:06 PM
Q2 2018 42 $427M +$163M -$147M +$16.3M AGN, IMMU, EXEL, DOVA, TSRO 13F-HR 8/14/2018, 04:09 PM
Q1 2018 36 $407M +$230M -$112M +$118M AGN, BMY, BMRN, SHPG, INSM 13F-HR 5/15/2018, 04:17 PM
Q4 2017 30 $284M +$182M -$133M +$48.9M AGN, SHPG, MYL, MRK, ABLX 13F-HR 2/14/2018, 06:08 PM
Q3 2017 32 $227M +$122M -$93.1M +$29.3M SGEN, CLVSQ, GSK, SGMO, FGEN 13F-HR 11/14/2017, 04:20 PM
Q2 2017 36 $185M +$70.7M -$36.1M +$34.5M SHPG, ALXN, GSK, CELG, PFE 13F-HR 8/14/2017, 04:40 PM
Q1 2017 29 $147M +$65.8M -$81.3M -$15.5M PFE, SHPG, CELG, GSK, ALXN 13F-HR 5/15/2017, 04:37 PM
Q4 2016 34 $153M +$102M -$69.5M +$32.6M SHPG, NVS, CELG, ALXN, PFE 13F-HR 2/14/2017, 05:00 PM
Q3 2016 31 $128M +$42.2M -$40.7M +$1.48M PFE, GSK, SHPG, XLRN, SGEN 13F-HR 11/14/2016, 04:08 PM
Q2 2016 35 $115M +$62.3M -$44.2M +$18.1M PFE, GSK, SHPG, SGEN, MYL 13F-HR 8/15/2016, 04:24 PM
Q1 2016 31 $95.2M +$54.8M -$22M +$32.8M CELG, SHPG, PFE, AGN, BMY 13F-HR 5/13/2016, 11:33 AM
Q4 2015 45 $70.5M $0 $0 PFE, BMY, CELG, MRK, SGEN 13F-HR 2/16/2016, 10:25 AM